Century Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.303; its P/E ratio is -1.58; Century Therapeutics is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 148.00K	$ 99.00K	$ 1.72M	$ 521.00K	$ 2.22M
Gross Profit	$ 148.00K	$ 99.00K	$ 1.72M	$ 521.00K	-
EBIT	$ -32.13M	$ -32.20M	$ -29.65M	$ -32.04M	$ -30.43M
EBITDA	-	$ -28.93M	$ -26.69M	$ -29.13M	$ -27.65M
Net Income Common Stockholders	$ -24.72M	$ -33.29M	$ -31.26M	$ -31.68M	$ -30.75M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 169.50M	$ 156.40M	$ 251.47M	$ 315.50M	$ 355.86M
Total Assets	$ 397.55M	$ 417.16M	$ 456.23M	$ 486.54M	$ 511.75M
Total Debt	$ 45.53M	$ 40.83M	$ 51.47M	$ 48.94M	$ 47.27M
Net Debt	$ -123.97M	$ -115.56M	$ -200.00M	$ -266.56M	$ -308.59M
Total Liabilities	$ 178.32M	$ 169.59M	$ 179.05M	$ 183.81M	$ 181.55M
Stockholders Equity	$ 219.23M	$ 247.57M	$ 277.18M	$ 302.74M	$ 330.20M
Cash Flow	-
Free Cash Flow	-	$ -23.75M	$ -34.21M	$ -29.18M	$ -34.05M
Operating Cash Flow	$ -13.65M	$ -19.25M	$ -29.22M	$ -22.91M	$ -24.24M
Investing Cash Flow	$ 4.22M	$ 6.97M	$ 31.34M	$ -4.27M	$ 22.66M
Financing Cash Flow	$ 300.00K	$ -10.12M	$ 448.00K	$ 95.00K	$ 138.00K

Currency in USD

Century Therapeutics Earnings and Revenue History

Income Statement >

Century Therapeutics Debt to Assets

Balance Sheet >

Century Therapeutics Cash Flow

Cash Flow >

Century Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing